taper_table

TL3 Regular · Ipswich, UK

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 13 November 2024 · last posted 21h · groups: pharmacists

154 posts, newest first. Showing up to 150.

Submitting a sample: the process end to end Replied, post #115 · Sourcing › Independent verification · 27 Jul 2026 · 5 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Reading order for a first week here, and what to skip until later — what changed since Replied, post #88 · Start Here › Welcome · 26 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #132 · Evidence › Journal club · 25 Jul 2026 · 2 likes A request rather than an answer: could whoever has the primary source for orforglipron phase 2 post it? I have seen the claim three times this month and each version…
Shakes versus food: a pragmatic assessment Replied, post #26 · Nutrition & Training › Protein & intake · 23 Jul 2026 · 0 likes Taking post #25 at face value and following it one step further. I have been on both sides of the shakes versus food argument in this category within eighteen months,…
Reading a home test result without over-claiming Replied, post #129 · Analytics › Home & field testing · 21 Jul 2026 · 28 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
What to bring: records that a clinician can actually use — a second dataset Replied, post #58 · Clinical › Prescriber conversations · 20 Jul 2026 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Transit times by route, from a logged dataset Replied, post #12 · Sourcing › Logistics · 16 Jul 2026 · 1 like Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
What is genuinely unknown about long-term amylin agonism Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 15 Jul 2026 · 5 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #27 · Practice › Interactions · 15 Jul 2026 · 2 likes Helpful, and easy to find again, which is half of what a good reply is.
What a certificate commits its issuer to — one year on Replied, post #102 · Analytics › COA interpretation · 4 Jul 2026 · 14 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
Follow-up: Reading an interaction checker output critically Replied, post #29 · Practice › Interactions · 3 Jul 2026 · 1 like Worth separating two things that post #27 runs together. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by…
Ultrasound and skinfolds: operator dependence in practice Replied, post #39 · Outcomes › Body composition · 1 Jul 2026 · 0 likes Small correction to my own earlier position on ultrasound and skinfolds. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
Prescription portability between countries Replied, post #77 · Access › International · 26 Jun 2026 · 12 likes Post #74 is right about the mechanism and I think understates the practical bit. I would put moderate confidence on the mainstream reading of prescription portability…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #83 · Safety › Contraindications · 22 Jun 2026 · 26 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
An appeal that succeeded, with the letter structure — the long version Replied, post #98 · Access › Insurance & coverage · 14 Jun 2026 · 33 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Micronutrient adequacy at low total intake Replied, post #59 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 2 likes Thank you for the correction. I would rather find out here than later.
Injecting into an area that has become firm: why not to Replied, post #35 · Practice › Administration · 8 Jun 2026 · 2 likes The arithmetic in post #32 is right; the assumption feeding it is the part to check. Needle length matters less than angle for subcutaneous delivery in most people. A…
An appeal that succeeded, with the letter structure Replied, post #7 · Access › Insurance & coverage · 6 Jun 2026 · 0 likes Narrowing post #6, because the general version has more than one answer. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final;…
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #14 · Compounds › Oral incretins · 3 Jun 2026 · 27 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
Reading a trial's population section before its results Replied, post #78 · Evidence › Trials · 2 Jun 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #12 · Clinical › Comorbidities · 1 Jun 2026 · 3 likes Second this, and I would have said it less carefully.
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #102 · Compounds › Tirzepatide · 29 May 2026 · 14 likes Where I part company with post #98, and it is a narrow parting. Where the Tirzepatide and nausea discussion usually stalls is that nobody wants to say "I do not know"…
Prescription portability between countries Replied, post #46 · Access › International · 28 May 2026 · 12 likes This follows post #44 rather than contradicting it. A regional experience posted here should say which year it describes. The archive keeps these permanently and they…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #45 · Practice › Storage & stability · 27 May 2026 · 1 like The arithmetic in post #44 is right; the assumption feeding it is the part to check. Clarity is a weak test. A solution can lose a significant fraction of its active…
Forced degradation studies: designing one that is informative Replied, post #64 · Analytics › Method validation · 27 May 2026 · 29 likes Everything in post #60 holds. The case it does not cover is the one I have. Something worth flagging about forced degradation studies: the strongest-sounding claims in…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #121 · Practice › Storage & stability · 23 May 2026 · 0 likes The reason Storing lyophilised material long term keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #63 · Practice › Administration · 23 May 2026 · 27 likes The version of Pinch that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #34 · Practice › Storage & stability · 19 May 2026 · 0 likes Post #31 answers the question as asked. The question underneath it is different. Visible particulate is a strong signal in the other direction: it is a reason to stop…
Reading a trial's population section before its results Replied, post #34 · Evidence › Trials · 19 May 2026 · 0 likes Confirming post #33 from a second method, which matters more than confirming it from a second person. A comparator at less than its maximum licensed dose changes what a…
A checklist for reading a certificate in under two minutes Replied, post #20 · Analytics › COA interpretation · 13 May 2026 · 0 likes On post #18 — agreed on the reasoning, with one qualification. The distinction between release testing and characterisation is one industrial documents make and retail…
Reconstitution volumes that produce round numbers, tabulated Replied, post #108 · Practice › Reconstitution · 5 May 2026 · 0 likes Post #104 put the caveat in the right place and I want to underline it. On reconstitution volumes I would separate what is worth knowing from what is worth acting on.…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #17 · Compounds › Semaglutide · 5 May 2026 · 0 likes Coming back to post #13, because the follow-up matters more than the original answer. The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #18 · Analytics › COA interpretation · 1 May 2026 · 5 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
Follow-up: What a statistical analysis plan adds that the paper does not Replied, post #3 · Evidence › Trials · 26 Apr 2026 · 25 likes Noted, and thank you for writing it out rather than summarising it.
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #47 · Evidence › Trials · 16 Apr 2026 · 1 like Second-hand on Subgroup analyses, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
List price versus negotiated price versus what you pay Replied, post #45 · Access › Pricing · 12 Apr 2026 · 24 likes One caution on list price versus negotiated price: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #21 · Devices › Syringes & needles · 10 Apr 2026 · 2 likes What I would tell a new member reading about 0.3 ml versus 0.5 ml for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #4 · Pharmacology › Receptor biology · 10 Apr 2026 · 29 likes Picking up post #2: that is the part I would want checked first. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #18 · Devices › Syringes & needles · 9 Apr 2026 · 21 likes Building on post #15 rather than restating it. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin…
Journal club: is percentage weight change the right endpoint? Replied, post #33 · Evidence › Journal club · 2 Apr 2026 · 3 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. Take it as a…
Managing an unplanned gap in supply Replied, post #80 · Access › Shortages · 31 Mar 2026 · 1 like Speaking only to managing an unplanned gap as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #126 · Access › Pricing · 25 Mar 2026 · 0 likes A note on scope: what I am saying about Price changes applies to the case in the first post and I would not extend it further without checking.
Cost per delivered dose, which is the number that matters Replied, post #60 · Access › Pricing · 24 Mar 2026 · 19 likes Answering the question post #58 raises rather than the one it answers. Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #14 · Clinical › Bloodwork · 22 Mar 2026 · 1 like Agreed on all of that, and I have nothing to add to it.
Anaesthesia and elective surgery: the aspiration question Replied, post #52 · Practice › Interactions · 16 Mar 2026 · 22 likes I would put moderate confidence on the mainstream reading of anaesthesia and elective surgery and no more. That is not scepticism for its own sake; it is where the…
Choosing which test to pay for, given a fixed budget Replied, post #25 · Sourcing › Independent verification · 14 Mar 2026 · 17 likes Taking post #24 at face value and following it one step further. Cross-checking one lot with two services independently is the cleanest test available and is rarely…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #65 · Compounds › Repair & healing peptides · 14 Mar 2026 · 17 likes Distinguishing three things in the Reading a preclinical wound-healing model discussion that keep getting used interchangeably: the observation, the proposed mechanism,…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #141 · Compounds › Semaglutide · 11 Mar 2026 · 22 likes Post #139 answers the question as asked. The question underneath it is different. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #6 · Evidence › Journal club · 11 Mar 2026 · 14 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. I would rather post the uncertainty than round it…
Personal import allowances, compared — a second dataset Replied, post #82 · Access › International · 9 Mar 2026 · 0 likes Adding a data point of agreement rather than a data point.
Pharmacy supply in the UK and the questions you will be asked Replied, post #69 · Regional › UK & Ireland · 9 Mar 2026 · 7 likes Clinical guidance published for prescribers is public and answers most eligibility questions here more precisely than the discussion does. Posted with less confidence…
Contributing data without breaching anyone's privacy Replied, post #57 · Data & Tools › Datasets · 6 Mar 2026 · 0 likes Include the denominator. A collection of reports without knowing how many people did not report is uninterpretable in the direction everybody wants to interpret it. I…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #75 · Sourcing › Vendor reports · 28 Feb 2026 · 0 likes Building on post #74 rather than restating it. Selective submission and selective reporting are the two easiest ways for a result to be shaped, and blinding addresses…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #19 · Research Methods › N-of-1 designs · 27 Feb 2026 · 0 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #29 · Practice › Dosing & titration · 16 Feb 2026 · 4 likes Where I part company with post #25, and it is a narrow parting. Doubling after a miss adds a peak for no gain and is not what any labelling in this class recommends.…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #20 · Practice › Administration · 13 Feb 2026 · 19 likes Nothing in this subcategory is medical advice and none of it is a substitute for a demonstration from somebody qualified to give one, which most prescribers will do…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #13 · Compounds › Tirzepatide · 11 Feb 2026 · 21 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
Cost per delivered dose, which is the number that matters Replied, post #45 · Access › Pricing · 4 Feb 2026 · 0 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #29 · Pharmacology › Pharmacokinetics · 31 Jan 2026 · 20 likes Post #26 is right about the mechanism and I think understates the practical bit. Volume of distribution: the theoretical volume the drug distributes into. For…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #76 · Wellbeing › Mental health · 13 Jan 2026 · 9 likes Worth separating two things that post #74 runs together. Mood changes reported during substantial weight loss have several plausible contributors and the drug is only…
Aggregates and why a purity assay may miss them entirely Replied, post #48 · Analytics › Impurities & related substances · 4 Jan 2026 · 23 likes I changed my mind about aggregates after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #37 · Access › International · 2 Jan 2026 · 0 likes Reframing Language barriers in accessing slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen",…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #35 · Analytics › Method validation · 24 Dec 2025 · 32 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #101 · Compounds › Oral incretins · 20 Dec 2025 · 0 likes Confirming post #100 from a second method, which matters more than confirming it from a second person. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an…
The decimal-point error, and the habit that catches it Replied, post #88 · Practice › Reconstitution · 17 Dec 2025 · 8 likes That is a cleaner way of putting what I was circling around.
Filter needles: when they help and what they cost you Replied, post #5 · Devices › Syringes & needles · 15 Dec 2025 · 0 likes If someone has run filter needles properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #8 · Pharmacology › Receptor biology · 10 Dec 2025 · 29 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #34 · Pharmacology › Pharmacokinetics · 9 Dec 2025 · 12 likes Worth separating two things that post #32 runs together. Taking Half-life seriously for a moment rather than deflecting: the honest position is that the community has…
Prescription requirements and telehealth models Replied, post #52 · Sourcing › Regulatory · 7 Dec 2025 · 9 likes Worth separating two things that post #48 runs together. Reading back through the prescription requirements and telehealth models threads from last year, the same three…
Run-in periods and the population they select Replied, post #29 · Evidence › Trials · 1 Dec 2025 · 0 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #80 · Practice › Reconstitution · 11 Nov 2025 · 23 likes Clear enough that I do not think I have a follow-up, which is unusual.
Where to report an adverse event officially, by region — a second dataset Replied, post #111 · Safety › Adverse events · 9 Nov 2025 · 1 like Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other on the site. That is one dataset and I would not build a rule on…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #2 · Compounds › Retatrutide · 8 Nov 2025 · 11 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Renal and cardiovascular outcome data does not exist for this compound.…
Tracking that stops updating and then resumes Replied, post #40 · Sourcing › Logistics · 28 Oct 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #116 · Lounge › Off topic · 23 Oct 2025 · 1 like That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #115 · Start Here › Welcome · 23 Oct 2025 · 2 likes Saving this. It is the version I will quote when the question comes round again.
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #108 · Analytics › HPLC & UHPLC · 15 Oct 2025 · 3 likes Retention time is only comparable within a laboratory on a given method. Quoting a retention time across two reports as evidence of identity is not a valid comparison.…
Guidelines revision: what changed and why — one year on Replied, post #24 · Meta › Announcements · 11 Oct 2025 · 19 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists. A modest claim,…
Gauge and length selection for subcutaneous injection Replied, post #38 · Devices › Syringes & needles · 10 Oct 2025 · 0 likes Post #34 put the caveat in the right place and I want to underline it. The reason gauge and length selection keeps being re-asked is that the answer is conditional and…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #73 · Practice › Reconstitution · 6 Oct 2025 · 9 likes Worth separating decimal-point error as a question about the compound from decimal-point error as a question about the documentation. They get answered by different…
Payment method and the leverage it gives you, ranked Replied, post #74 · Sourcing › Payments · 25 Sep 2025 · 1 like A first order deliberately smaller than you need is the standard risk-limiting approach here and it costs a little more per unit for a reason. Not disagreeing with…
EU-wide position versus national implementation — what changed since Replied, post #3 · Regional › European Union · 22 Sep 2025 · 14 likes Thank you — that answers what I came here to find out.
Adolescents: a distinct evidence base — one year on Replied, post #17 · Clinical › Special populations · 17 Sep 2025 · 0 likes The most useful thing anyone has posted about Adolescents in this category was a table of what had been measured and by whom. That is what I would want again.
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #12 · Evidence › Journal club · 16 Sep 2025 · 14 likes Post #11 answers the question as asked. The question underneath it is different. The most common failure mode is spending fifty minutes on the effect size and ten on…
Follow-up: Why appetite effects are mostly central Replied, post #38 · Pharmacology › Receptor biology · 11 Sep 2025 · 0 likes Narrowing post #37, because the general version has more than one answer. Nothing in receptor biology tells you what is in the vial, which is worth remembering when a…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #88 · Evidence › Journal club · 8 Sep 2025 · 0 likes Where I part company with post #86, and it is a narrow parting. The most common failure mode is spending fifty minutes on the effect size and ten on the population.…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #21 · Data & Tools › Datasets · 7 Sep 2025 · 0 likes Everything in post #19 holds. The case it does not cover is the one I have. The reason Aggregated purity results across four keeps being re-asked is that the answer is…
Journal club: the retatrutide phase 2 obesity paper Replied, post #6 · Evidence › Journal club · 31 Aug 2025 · 1 like Picking up post #4: that is the part I would want checked first. Suggest the next paper at the end of the session rather than by message afterwards. The room has just…
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #8 · Compounds › Tirzepatide · 24 Aug 2025 · 3 likes Distinguishing three things in the tirzepatide molecular mass discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Started this topic · Compounds › Tirzepatide · 23 Aug 2025 · 0 likes Asking directly, because I could not find a straight answer: Tirzepatide molecular mass and the charge states you would expect on ESI — does this still hold? The…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #20 · Analytics › Method validation · 20 Aug 2025 · 28 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
A preprint whose numbers changed substantially at publication Replied, post #20 · Evidence › Preprints · 15 Aug 2025 · 19 likes Everything in post #18 holds. The case it does not cover is the one I have. Where a preprint's numbers are the basis of a claim being repeated here, someone should…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #120 · Compounds › Semaglutide · 15 Aug 2025 · 12 likes Taking post #118 at face value and following it one step further. Injection site does not appear to matter much for semaglutide exposure. The published comparisons of…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #33 · Practice › Side effects · 14 Aug 2025 · 12 likes Small methodological point on Fatigue: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Reading a combination trial: attributing effect to components Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 13 Aug 2025 · 0 likes Narrowing the opening post, because the general version has more than one answer. Is synergy the right word for the combination data? A phase 2 trial cannot establish…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #29 · Compounds › Repair & healing peptides · 11 Aug 2025 · 0 likes Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather…
Travel coolers and how long they really hold Replied, post #75 · Devices › Cold chain · 7 Aug 2025 · 3 likes Second-hand on travel coolers, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #32 · Documentation › Doc review · 28 Jul 2025 · 31 likes Point three stops most nominations. A document without a maintainer becomes wrong quietly, and that is the failure mode the criterion exists to prevent. It is one…
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #7 · Sourcing › Red flags · 23 Jul 2025 · 2 likes I read post #3 twice before replying, because I had assumed the opposite. The most useful contribution to this subcategory is a resolved case written up with the…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #19 · Compounds › Retatrutide · 22 Jul 2025 · 0 likes Everything in post #17 holds. The case it does not cover is the one I have. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote —…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #68 · Compounds › Oral incretins · 21 Jul 2025 · 0 likes Coming back to post #66, because the follow-up matters more than the original answer. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #83 · Evidence › Trials · 21 Jul 2025 · 1 like Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 6 Jul 2025 · 8 likes Post #9 describes the usual case. This is about the unusual one. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #14 · Compounds › Oral incretins · 2 Jul 2025 · 0 likes I keep a log for SOUL trial and oral semaglutide specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost…
Repeatability versus intermediate precision Replied, post #69 · Analytics › Method validation · 26 Jun 2025 · 17 likes Post #67 put the caveat in the right place and I want to underline it. The confident answers on repeatability versus intermediate precision and the well-sourced answers…
Needle changes between doses on a reusable pen Replied, post #15 · Devices › Pens & autoinjectors · 18 Jun 2025 · 0 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
Antibiotics and a course of something with delayed emptying Replied, post #62 · Practice › Interactions · 11 Jun 2025 · 0 likes Reading this antibiotics thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Coming back to: Official shortage notices and what they authorise Replied, post #22 · Access › Shortages · 5 Jun 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Pre-registering a personal experiment, seriously Replied, post #71 · Research Methods › N-of-1 designs · 31 May 2025 · 10 likes Narrowing post #70, because the general version has more than one answer. Pre-registering a personal experiment sits at the boundary between what this community can…
Pre-registering a personal experiment, seriously Replied, post #35 · Research Methods › N-of-1 designs · 28 May 2025 · 13 likes Agreed on pre-registering a personal experiment, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting…
Asking about a compound your prescriber has not heard of Replied, post #50 · Clinical › Prescriber conversations · 27 May 2025 · 18 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #8 · Data & Tools › Calculators · 21 May 2025 · 0 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives. Caveat: everything above…
Foaming during reconstitution and whether it matters Replied, post #13 · Practice › Reconstitution · 20 May 2025 · 0 likes Counterpoint on foaming during reconstitution, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the…
Journal club: SURMOUNT-1, read without the press release Replied, post #116 · Evidence › Journal club · 14 May 2025 · 30 likes Nothing to add on the substance. Thank you for taking the question at face value.
Metformin co-administration and additive GI effects Replied, post #31 · Practice › Interactions · 3 May 2025 · 12 likes This follows post #28 rather than contradicting it. Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion,…
Units, standards, and other things that quietly hold the world together Replied, post #35 · Lounge › Off topic · 3 May 2025 · 0 likes Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work. That is the…
Review: a draft on reconstitution arithmetic, with objections Replied, post #121 · Documentation › Doc review · 23 Apr 2025 · 0 likes Post #118 is right about the mechanism and I think understates the practical bit. Small correction to my own earlier position on draft on reconstitution arithmetic. I…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #63 · Evidence › Journal club · 20 Apr 2025 · 0 likes Post #60 is the version of this I will quote in future. One addition. Sessions on negative or null results are consistently the most instructive and the hardest to get…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #27 · Evidence › Journal club · 18 Apr 2025 · 1 like The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping. I…
Reading order for a first week here, and what to skip until later Replied, post #81 · Start Here › Welcome · 13 Apr 2025 · 24 likes I have been on both sides of the reading order argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Adjudicated events and why the definition matters — the long version Replied, post #87 · Evidence › Trials · 8 Apr 2025 · 2 likes Counterpoint on Adjudicated events, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #55 · Compounds › Semaglutide · 28 Mar 2025 · 8 likes Everything in post #51 holds. The case it does not cover is the one I have. I keep a log for SELECT specifically because my memory of it turned out to be systematically…
Counter-ion form: the field almost nobody reports — one year on Replied, post #129 · Analytics › COA interpretation · 27 Mar 2025 · 2 likes Post #125 describes the usual case. This is about the unusual one. Before the thread moves on from Counter-ion form — what is the sample size behind the claim? I am not…
Antibiotics and a course of something with delayed emptying Started this topic · Practice › Interactions · 5 Mar 2025 · 0 likes Antibiotics and a course of something with delayed emptying — setting out what I have, and where I think it stops being reliable. Something about antibiotics does not…
Counter-ion form: the field almost nobody reports — one year on Replied, post #39 · Analytics › COA interpretation · 1 Mar 2025 · 4 likes Counter-ion form: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
About the Red flags category Replied, post #3 · Sourcing › Red flags · 1 Mar 2025 · 27 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
[2026 update] US compounding rules and how they changed Replied, post #2 · Regional › North America · 27 Feb 2025 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Distinguishing a deletion sequence by mass alone Replied, post #95 · Analytics › Mass spectrometry · 16 Feb 2025 · 11 likes Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass spectrum from a peptide can look busier than expected. If the premise is…
Reading a supplementary appendix and finding the interesting part Replied, post #90 · Evidence › Trials · 11 Feb 2025 · 19 likes Post #89 answers the question as asked. The question underneath it is different. Risk of bias: structured appraisal of internal validity. Key things to assess:…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #44 · Evidence › Meta-analyses · 2 Feb 2025 · 22 likes Coming back to post #42, because the follow-up matters more than the original answer. Random versus fixed effects is a good example of a question where the honest…
Sample size intuition for a personal experiment Replied, post #5 · Research Methods › Statistics · 21 Jan 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Recovery when intake is low: what to cut first Replied, post #35 · Nutrition & Training › Resistance training · 11 Jan 2025 · 1 like This follows post #32 rather than contradicting it. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to…
Books and papers worth reading that are not about this at all Replied, post #12 · Lounge › Off topic · 5 Jan 2025 · 28 likes What I would check first on books and papers is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Coming back to: When to suspect the method rather than the sample Replied, post #131 · Analytics › Method validation · 25 Dec 2024 · 0 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
Reading an MS report that only gives you a single number — the long version Started this topic · Analytics › Mass spectrometry · 21 Dec 2024 · 25 likes Reading an MS report that only gives you a single number — the long version — setting out what I have, and where I think it stops being reliable. I would like to…
Persistent vomiting and the threshold for seeking help — one year on Replied, post #28 · Safety › Adverse events · 21 Dec 2024 · 10 likes Taking post #25 at face value and following it one step further. Two claims get bundled together under Persistent vomiting and they need separating. The descriptive one…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #30 · Compounds › Secretagogues & GH axis · 20 Dec 2024 · 0 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
Why our vendor pages link the storefront and mark it sponsored Replied, post #17 · Sourcing › Vendor reports · 19 Dec 2024 · 17 likes Saving this. It is the version I will quote when the question comes round again.
Promotion criteria, and the one that stops most nominations Replied, post #140 · Documentation › Doc review · 14 Dec 2024 · 8 likes Nothing to add, except that this is the answer I would give if asked.
What we do not know about retatrutide, listed explicitly Replied, post #11 · Compounds › Retatrutide · 3 Dec 2024 · 31 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #22 · Sourcing › Red flags · 3 Dec 2024 · 3 likes I read post #18 twice before replying, because I had assumed the opposite. Where somebody posts a concern, ask what would resolve it before arguing about it. Half of…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #63 · Clinical › Special populations · 25 Nov 2024 · 10 likes Body weight at the extremes of the studied range affects exposure and the trials rarely reported enough to say by how much.
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #83 · Compounds › Repair & healing peptides · 18 Nov 2024 · 0 likes The version of reading a preclinical wound-healing model that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #6 · Nutrition & Training › Protein & intake · 15 Nov 2024 · 22 likes Answering the question post #4 raises rather than the one it answers. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #8 · Access › Shortages · 8 Oct 2024 · 9 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
Pen wastage and its effect on real cost Replied, post #31 · Access › Pricing · 4 Oct 2024 · 0 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
Progressive overload when the scale is falling — one year on Replied, post #77 · Nutrition & Training › Resistance training · 21 Sep 2024 · 26 likes Building on post #75 rather than restating it. Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #39 · Sourcing › Independent verification · 6 Sep 2024 · 33 likes Noted, and I have changed what I was going to do on the strength of it.
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #17 · Compounds › Retatrutide · 3 Sep 2024 · 31 likes No notes. Posting so the count is not one.
Circumference measurements as a poor man's composition estimate Replied, post #88 · Outcomes › Body composition · 22 Aug 2024 · 0 likes On circumference measurements, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is…